2:30PM – 3:30PM
How Virtual (Decentralized Clinical) Trials Could Improve Safety Monitoring and Improve Patient Follow-up During a Trial for Diagnostics and Devices
Brittany Goldberg, M.D., Medical Officer, FDA
Alka Shaunik, M.D., Senior Medical Director, Global Medical Affairs, SANOFI
Matthew Moyer, M.S., MBA, PMP, Director, Clinical Supply Technology, Merck
- Dive into how virtual trials can augment or facilitate follow-up of subjects to assess the safety of devices.
- Review how virtual trials can play a role in assessing potential endpoints to assess the efficacy of devices.
- Discuss how virtual trials can be utilized to support or supplement device registries/electronic medical records.